| Literature DB >> 28533857 |
Awoke Derbie1, Derese Hailu2, Daniel Mekonnen1, Bayeh Abera1, Gashaw Yitayew2.
Abstract
INTRODUCTION: Antimicrobial resistance among bacteria that cause urinary tract infection (UTI) has been increasing since the introduction of chemotherapy. This study was aimed to assess the types of isolates from patients with UTI and to determine their current antimicrobial susceptibility profile.Entities:
Keywords: Bahir Dar; Ethiopia; UTI; antimicrobial resistance; uropathogens
Mesh:
Substances:
Year: 2017 PMID: 28533857 PMCID: PMC5429430 DOI: 10.11604/pamj.2017.26.134.7827
Source DB: PubMed Journal: Pan Afr Med J
Bacteriological culture results distribution by age and sex in Bahir Dar Regional Research Laboratory Center, December, 2014
| N (%) | N (%) | p-value | |
|---|---|---|---|
|
|
|
| |
| <5 | 28 (9) | 13 (9.6) | |
| 5-15 | 38 (12.3) | 7 (5.1) | |
| 16-35 | 162 (52.3) | 76 (55.9) | |
| 36-50 | 56 (18.1) | 20 (14.7) | |
| >50 | 26 (8.4) | 20 (14.7) | |
| Total | 310 (100) | 136 (100) | |
|
|
|
| |
| Female | 192 (61.9) | 107 (78.7) | |
| Male | 118 (38.1) | 29 (21.3) | |
| Total | 310 (100) | 136 |
Antimicrobial resistance pattern of bacterial isolates from urine sample at Bahir Dar Regional Health Research Laboratory Center, December, 2014
| Antimicrobial agent | CNS | Ent. Spp | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ampicillin | 64 | 89.1 | 17 | 100 | 1 | 100 | 8 | 100 | 7 | 85.7 | 3 | 100 | NP | NP | 1 | 0 | 3 | 100 |
| Tetracycline | 62 | 66.1 | 18 | 27.8 | 10 | 60 | 5 | 40 | 7 | 57.1 | 3 | 100 | 5 | 40 | 1 | 0 | 3 | 66.7 |
| Ciprofloxacin | 64 | 64.4 | 19 | 21 | 9 | 33.3 | 8 | 0 | 6 | 66.7 | 3 | 33.3 | 5 | 0 | NP | NP | 3 | 66.7 |
| SXT | 62 | 64.5 | 18 | 50 | 8 | 87.5 | 7 | 71.4 | 7 | 71.4 | 3 | 66.7 | 3 | 100 | 1 | 0 | 3 | 100 |
| Gentamycin | 58 | 27.6 | 15 | 40 | 2 | 50 | 7 | 0 | 7 | 57.1 | 3 | 100 | NP | NP | NP | NP | 2 | 50 |
| Nitrofrantoin | 32 | 25 | 11 | 81.8 | 3 | 0 | NP | NP | 5 | 80 | 2 | 50 | 1 | 0 | 1 | 0 | 3 | 33.3 |
| AUG | 42 | 78.6 | 13 | 84.6 | NP | NP | 4 | 75 | 5 | 80 | 2 | 50 | NP | NP | NP | NP | 2 | 100 |
| Norfloxacin | 63 | 27 | 18 | 33.3 | NP | NP | 7 | 0 | 6 | 50 | 2 | 100 | NP | NP | NP | NP | 2 | 100 |
| Pepracillin | 4 | 0 | ||||||||||||||||
| Cefoxitin | 7 | 85.7 | 6 | 33.3 | ||||||||||||||
Key: #T: number of isolates tested against each antimicrobial agent; %R: percent of isolates resistance to the respective antimicrobial agent; NP: not performed; SXT: Trimetoprim-sulphamethoxazole; AUG: Amoxicillin/clavunate; Ent: Enterobacter.
All isolates were not tested for all indicated antimicrobials equally; this is because the agents might stock out at some period. In addition, some antibiotics such as mecillinam and fosfomycin xere not tested due to their regular absence in the laboratory.
Figure 1Percentage distribution of isolated bacteria from urine sample in Bahir Dar Regional Research Laboratory Center, December, 2014
Overall sensitivity and resistance profile of antimicrobial agents tested for bacterial isolates from urine sample, at Bahir Dar Regional Health Research Laboratory Center, December 2014
| Antimicrobial agent | Number of antimicrobials tested | Susceptibility pattern | ||
|---|---|---|---|---|
| Sensitive, N (%) | Intermediate, N (%) | Resistant, (%) | ||
| Ampicillin | 116 | 7 (6) | 3(2.6) | 106 (91.4) |
| Tetracycline | 126 | 45 (35.7) | 7 (5.6) | 74 (58.7) |
| Ciprofloxacin | 130 | 84 (64.6) | 4 (3.1) | 42 (32.3) |
| SXT | 126 | 40 (31.7) | 2 (1.6) | 84 (66.7) |
| Gentamycin | 106 | 68 (64.2) | 2 (1.9) | 36 (34) |
| Nitrofrantoin | 64 | 27(42.2) | 9 (14.1) | 28 (43.6) |
| AUG | 77 | 13 (16.9) | 3 (3.9) | 61 (79.2) |
| Norfloxacin | 110 | 67 (60.9) | 7 (6.4) | 36 (32.7) |
| Pepracillin | 4 | 4 (100) | 0 | 0 |
| Cefoxitin | 14 | 6 (42.5) | 0 | 8 (57.5) |